% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Asokan:169931,
author = {S. Asokan$^*$ and O. R. Bandapalli$^*$},
title = {{CXCL}8 {S}ignaling in the {T}umor {M}icroenvironment.},
journal = {Advances in experimental medicine and biology},
volume = {1302},
issn = {0065-2598},
address = {[Heidelberg]},
publisher = {Springer},
reportid = {DKFZ-2021-01637},
isbn = {978-3-030-62657-0 (print)},
pages = {25-39},
year = {2021},
note = {#EA:W071#LA:B062#},
abstract = {The tumor microenvironment represents a dynamic and complex
cellular network involving intricate communications between
the tumor and highly heterogeneous groups of cells,
including tumor-supporting immune and inflammatory cells,
cancer-associated fibroblasts, endothelial cells,
tumor-associated macrophages, adipose cells, and pericytes.
Associated with a variety of growth factors, chemokines,
cytokines, and other signaling molecules, the interaction
between the tumor microenvironment and the tumor cells
empowers aggressiveness of tumor by enhancing its
survivability. CXCL8 (also known as Interleukin 8), a
multifunctional proinflammatory chemokine that was initially
classified as a neutrophil chemoattractant, recently has
been found to be a key contributor in tumorigenesis. The
upregulation of CXCL8 at the tumor invasion front in several
human cancers suggests its interplay between the tumor and
its microenvironment rendering tumor progression by
enhancing angiogenesis, tumor genetic diversity, survival,
proliferation, immune escape, metastasis, and multidrug
resistance. The autocrine and paracrine modulation of CXCL8
via the chemokine receptors CXCR1/2 promotes several
intracellular signaling cascades that fosters
tumor-associated inflammation, reprogramming,
epithelial-mesenchymal transition, and neovascularization.
Hence, decrypting the regulatory/signaling cascades of CXCL8
and its downstream effects may harbor prognostic clinical
prospects of a tumor microenvironment-oriented cancer
therapeutics.},
keywords = {Endothelial Cells / Humans / Interleukin-8 / Receptors,
Interleukin-8A / Receptors, Interleukin-8B / Tumor
Microenvironment / Angiogenesis (Other) / Angiogenic switch
(Other) / Autocrine signaling (Other) / CXCL8 (Other) /
CXCR1/2 (Other) / Cancer (Other) / Chemokines (Other) /
Epithelial-mesenchymal transition (Other) / Interleukin-8
(Other) / Intracellular signaling cascade (Other) / Invasion
front (Other) / Metastasis (Other) / Survival (Other) /
Tumor microenvironment (Other) / Tumor-related inflammation
(Other) / Interleukin-8 (NLM Chemicals) / Receptors,
Interleukin-8A (NLM Chemicals) / Receptors, Interleukin-8B
(NLM Chemicals)},
cin = {B062 / HD01},
ddc = {570},
cid = {I:(DE-He78)B062-20160331 / I:(DE-He78)HD01-20160331},
pnm = {312 - Funktionelle und strukturelle Genomforschung
(POF4-312)},
pid = {G:(DE-HGF)POF4-312},
typ = {PUB:(DE-HGF)3 / PUB:(DE-HGF)16},
pubmed = {pmid:34286439},
doi = {10.1007/978-3-030-62658-7_3},
url = {https://inrepo02.dkfz.de/record/169931},
}